Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | IKBKB | O14920 | 1/20 | 0.30 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22280896 | 0.84 | ALDH1A1 (0.34) | — | |
| SCHEMBL22280911 | 0.79 | CCNE1 (0.33) | GRIA1CCNE1CDK2IKBKB | |
| SCHEMBL22262082 | 0.79 | CDK2 (0.33) | GRIA1CCNE1CDK2IKBKB | |
| SCHEMBL22280897 | 0.78 | DRD1 (0.33) | IKBKB | |
| SCHEMBL21918379 | 0.75 | PDE4D (0.40) | CCNE1CDK2 | |
| SCHEMBL22280712 | 0.74 | PDE2A (0.43) | — | |
| SCHEMBL20561490 | 0.73 | IKBKB (0.35) | GRIA1CCNE1CDK2IKBKB | |
| SCHEMBL12076941 | 0.67 | MAPT (0.41) | CCNE1CDK2 | |
| SCHEMBL29808108 | 0.67 | MAPT (0.41) | CCNE1CDK2 | |
| SCHEMBL22349169 | 0.66 | CCNE1 (0.37) | CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200239505-A1 | BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239505-A1 | BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES | EML4, TYR, TYMP | GRIA1 4481/4885CCNE1 3005/4885CDK2 435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.